Related Experiment Video
Updated: Feb 21, 2026

Defining Gene Functions in Tumorigenesis by Ex vivo Ablation of Floxed Alleles in Malignant Peripheral Nerve Sheath Tumor Cells
Published on: August 25, 2021
TERT structural rearrangements in metastatic pheochromocytomas
Trisha Dwight1,2, Aidan Flynn3,4, Kaushalya Amarasinghe5
1Cancer GeneticsKolling Institute, Royal North Shore Hospital, Sydney, New South Wales, Australia trisha.dwight@sydney.edu.au rtothill@unimelb.edu.au.
Genomic rearrangements near the TERT gene can activate its expression in metastatic pheochromocytomas (PC) and paragangliomas (PGL), offering potential new biomarkers for predicting tumor spread.
Area of Science:
- Endocrinology
- Oncology
- Genetics
Background:
- Pheochromocytomas (PC) and paragangliomas (PGL) are rare endocrine tumors with unpredictable metastatic potential.
- Understanding the genetic drivers of metastasis is crucial for early diagnosis and risk stratification.
- TERT activation is linked to malignancy, but its mechanism in PC/PGL is largely unknown.
Purpose of the Study:
- To investigate novel mechanisms of TERT activation in metastatic PC/PGL.
- To identify potential biomarkers for predicting metastatic potential in these tumors.
Main Methods:
- Analysis of 35 PC and 4 PGL samples.
- Whole genome sequencing to identify structural variations.
- Assessment of TERT expression, promoter mutations, and DNA methylation.
Main Results:
- Three primary PCs with metastases showed elevated TERT expression without typical promoter mutations or methylation.
- Somatic structural alterations near the TERT locus were identified in two metastatic tumors.
- Genomic rearrangements repositioned super-enhancers near the TERT promoter, driving aberrant gene expression.
Conclusions:
- Structural variations, not just promoter mutations, can activate TERT in metastatic PC/PGL.
- TERT activation via super-enhancer proximity is a potential mechanism driving metastasis in these endocrine tumors.
- These findings may lead to new diagnostic biomarkers for metastatic risk.
Related Concept Videos
Metastasis
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Transducer Mechanism: Enzyme-Linked Receptors
Major types that are helpful drug targets include:
Tumor Progression
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Cadherins in Tissue Organization
Cell Sorting During Development
Cell sorting plays an...
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
The Tumor Microenvironment

